Skip to content
Search AI Powered

Latest Stories

Turns Out Trump and Top GOP Donor Have a 'Financial Stake' in That Anti-Malarial Drug Trump Keeps Touting

Turns Out Trump and Top GOP Donor Have a 'Financial Stake' in That Anti-Malarial Drug Trump Keeps Touting
JIM WATSON/AFP via Getty Images

Despite numerous cautions from medical experts—including those on his staff—President Donald Trump continues to tout hydroxychloroquine as a promising treatment for the virus that's brought daily life in the United States to a standstill.

The drug has undergone no clinical trials to scientifically test its efficacy on the virus, and the evidence on its behalf is anecdotal at best. One Fox News guest, Access Health International Chairman William Haseltine, called it a "quack cure."


The drug, primarily used for malaria and lupus, is now facing a shortage that potentially jeopardizes the health and safety of those who need it, thanks to a surge in demand after the President's numerous endorsements.

But why is the President, who has no related experience in medicine or pandemics, so dead set on promoting this drug?

A new report from the New York Times may give some insight.

The piece details the medical community's divided reaction to Trump's promotion of hydroxychloroquine, but it also mentions the financial stake the Trump family holds in the drug's success.

The report states:

"Mr. Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine."

According to the Times, as recently as last year, the President reported three family trusts in a mutual fund whose largest investment was in Sanofi—the maker of Plaquenil.

Trump's attempts to profit from the Presidency are nothing new, so—sadly—people weren't surprised.




It's possible that Trump didn't know these mutual funds held some stock in Sanofi, and a spokesperson for the company says it no longer distributes Plaquenil to the United States, but the financial stake in it extends deeper into Trump's web.

The billionaire and staunch Republican Ken Fisher—a donor to Trump—is one of Sanofi's largest shareholders. Secretary of Commerce Wilbur Ross owned a company which invested in Sanofi as well.

Some speculate that Trump is, yet again, using the presidency for profit—even in a pandemic.





Unbelievable.


More from People/donald-trump

Jeff Ross
Mike Coppola/Variety via Getty Images

Comedian Jeff Ross Shares Photos Of Puffed Up Lip After Allergic Reaction To Ice Cream

Insult comic Jeff Ross revealed he had a medical emergency after a show Saturday night that resulted in a trip to the ER. However, he assured fans the show must go on despite "looking like Mickey Rourke at the end of The Wrestler."

Ross recounted the ordeal on Instagram, showing his swollen lip taking over his face from eating burrata ice cream after his Take a Banana for the Ride show in Mill Valley, California, near San Francisco.

Keep ReadingShow less
screenshot of Jesse Watters on Fox News
Fox News

Jesse Watters Offers Mind-Numbing New Claim About Masculinity—And Is Instantly Dragged

Problematic Fox News MAGA pundit Jesse Watters has made another bizarre claim about masculinity.

Having already taken exception with eating ice cream, drinking milkshakes, and taking bubble baths, Watters is now targeting tech jobs.

Keep ReadingShow less
Donald Trump with the Dodgers
Kevin Dietsch/Getty Images

Trump Leaves Everyone Confused With Hilariously Bizarre Word Salad Tribute To The Dodgers

President Donald Trump was widely mocked after he welcomed the 2024 World Series-winning Los Angeles Dodgers to the White House on Monday with a bizarre, tangential, and rambling speech.

The team arrived at the White House on Monday morning, where Trump, in his remarks, praised two-way star Shohei Ohtani and infielder Mookie Betts. The Dodgers had defeated the New York Yankees in five games to clinch their second World Series title in five seasons.

Keep ReadingShow less
Donald Trump
Kevin Dietsch/Getty Images

Trump Roasted After Giving Clunky New Nickname To People Criticizing His Tariffs

President Donald Trump was criticized after he pushed back against critics of his tariffs, coming up with a new nickname for the "weak and stupid" people who oppose them.

The Trump administration’s newly imposed tariffs on imports from various countries have unsettled consumers, triggered a trade war, disrupted global markets, and sparked widespread fears of a potential recession in the U.S. and beyond.

Keep ReadingShow less

Childhood Experiences People Thought Were 'Normal' But Weren't At All

Content Warning: Child neglect, child abuse, narcissism, gaslighting, people-pleasing, and other traumatic childhood experiences

It's important for us to work on ourselves, to continue bettering ourselves throughout our limited time on this earth, and a key way of doing that is acknowledging what we do not know, and working on that.

Keep ReadingShow less